Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep-Oct;87(5):704-706.
doi: 10.25259/IJDVL_1158_20.

Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia

Andrea Giuseppe Faraci  1 , Giovanni Genovese  1 , Silvia Ferrucci  2 , Angelo Valerio Marzano  1
Affiliations
Free article
Case Reports

Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia

Andrea Giuseppe Faraci et al. Indian J Dermatol Venereol Leprol. 2021 Sep-Oct.
Free article
No abstract available

PubMed Disclaimer

References

    1. Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, et al. Diagnostic criteria of ulcerative pyoderma gangrenosum: A Delphi consensus of international experts. JAMA Dermatol. 2018; 154:461-6
    1. Wu BC, Patel ED, Ortega-Loayza AG,. Drug-induced pyoderma gangrenosum: A model to understand the pathogenesis of pyoderma gangrenosum. Br J Dermatol. 2017; 177:72-83
    1. Wang JY, French LE, Shear NH, Amiri A, Alavi A,. Drug-induced pyoderma gangrenosum: A review. Am J Clin Dermatol. 2018; 19:67-77
    1. Pinato DJ, Sharma R,. Imatinib induced pyoderma gangrenosum. J Postgrad Med. 2013; 59:244-5
    1. Napier RJ, Norris BA, Swimm A, Giver CR, Harris WA, Laval J, et al. Low doses of imatinib induce myelopoiesis and enhance host antimicrobial immunity. PLoS Pathog. 2015; 11:e1004770

MeSH terms